Adaptive Biotechnologies ADPT Free cash flow margin
Free cash flow margin at other companies
Other financials
Where this comes from
Calculated from Adaptive Biotechnologies’s reported figures.
Based on trailing twelve months.
The official record: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Adaptive Biotechnologies's free cash flow margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Adaptive Biotechnologies's free cash flow margin?
- Adaptive Biotechnologies (ADPT) reported free cash flow margin of -10.5% in Q1 2026.
- How has Adaptive Biotechnologies's free cash flow margin changed year-over-year?
- Adaptive Biotechnologies's free cash flow margin increased by 77.6% year-over-year, from -46.8% to -10.5%.
- What is the long-term trend for Adaptive Biotechnologies's free cash flow margin?
- Over 5 years (2020 to 2025), Adaptive Biotechnologies's free cash flow margin has grown at a -36.1% compound annual growth rate (CAGR), from -171.3% to -18.2%.
- What does free cash flow margin mean?
- Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.